Join
Live feed
·
INSIDERFilingvia Quantisnow
MiNK Therapeutics Inc. logo

Director Kadlec Robert Peter was granted 12,286 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
INKT· MiNK Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INKT (MiNK Therapeutics Inc.) and more on Quantisnow.

Director Kadlec Robert Peter was granted 12,286 shares (SEC Form 4) | Quantisnow